Dr Martin Cross is a highly regarded pharmaceutical executive with over 30 years of experience including corporate and industry leadership roles directly influencing healthcare policy and government legislation in Australia and global business management, marketing and sales roles.
From 2013 to 2015, Dr Cross was chair of Medicines Australia, the country’s peak body representing the research-based pharmaceutical industry in Australia. Prior to leading Medicines Australia, Dr Cross was chair of both the Generics Medicine Industry Association and Pharmaceutical Industry Council from 2010 to 2013. During this time, Dr Cross was also managing director of Alphapharm in Australia and New Zealand, with responsibility for 750 employees and sales of over US $500m per annum. From 2003 to 2008, Dr Cross was country head and managing director of Novartis Australia and New Zealand, and head of global marketing and sales capabilities from 2001 to 2003, and was based in Switzerland.
